Tvardi Therapeutics (TVRD) Change in Receivables: 2015-2017
Historic Change in Receivables for Tvardi Therapeutics (TVRD) over the last 2 years, with Dec 2017 value amounting to $26,000.
- Tvardi Therapeutics' Change in Receivables rose 192.86% to $26,000 in Q4 2017 from the same period last year, while for Dec 2017 it was $36,000, marking a year-over-year increase of 414.29%. This contributed to the annual value of -$2.4 million for FY2024, which is 376.36% down from last year.
- Latest data reveals that Tvardi Therapeutics reported Change in Receivables of $26,000 as of Q4 2017, which was up 133.33% from -$78,000 recorded in Q3 2017.
- In the past 5 years, Tvardi Therapeutics' Change in Receivables registered a high of $896,000 during Q1 2017, and its lowest value of -$2.1 million during Q4 2015.
- Over the past 3 years, Tvardi Therapeutics' median Change in Receivables value was -$28,000 (recorded in 2016), while the average stood at -$224,444.
- The largest annual percentage gain for Tvardi Therapeutics' Change in Receivables in the last 5 years was 1,766.67% (2017), contrasted with its biggest fall of 756.91% (2017).
- Quarterly analysis of 3 years shows Tvardi Therapeutics' Change in Receivables stood at -$2.1 million in 2015, then surged by 98.64% to -$28,000 in 2016, then skyrocketed by 192.86% to $26,000 in 2017.
- Its last three reported values are $26,000 in Q4 2017, -$78,000 for Q3 2017, and -$808,000 during Q2 2017.